It’s one thing for Georgians to legally possess cannabis oil for the treatment of eight approved medical conditions. It’s another thing to acquire it in the first place.
That’s the dilemma families across Georgia have faced since the state launched a registry in June to certify eligible patients to use the drug.
And the Commission on Medical Cannabis held its second meeting Wednesday in Atlanta to begin addressing the quandary.
The manufacture, sale and purchase of cannabis oil remains out of bounds, and while the state is exploring clinical trials, lawmakers have urged caution before proceeding down the production line. [Read more at the Gainesville Times]
Your email address will not be published. Required fields are marked *
Name *
Email *
Website
Save my name, email, and website in this browser for the next time I comment.
Comment *
Notify me of follow-up comments by email.
Notify me of new posts by email.
Δ
The long wait on whether Floridians will get a chance to vote to legalize recreational cannabis for adults 21 and older is almost over, as the Florida Supreme Court is…
Missouri’s health department on Wednesday stripped two coveted marijuana micro-licenses tied to an out-of-state company that had been accused of predatory practices and had listed the licenses for resale. The…
Big Island Grown (BIG) is a vertically integrated cannabis company based in Kailua-Kona, Hawaii County, on the Big Island of Hawaii, whose reach now extends to several islands in the…
There are three primary ways that brands can use social media platforms for marketing: organic posts, shared posts, and paid posts. With paid posts still off limits to most businesses…